#3-38E. LIBERATE-D: Is Less Dialysis More for AKI Recovery? (JAMA, 2026)

Does the standard practice of thrice-weekly hemodialysis inadvertently delay renal recovery in patients with acute kidney injury? In this episode, we examine the LIBERATE-D trial, a multicenter randomized clinical trial comparing a conservative dialysis strategy against conventional management. The researchers assigned 220 hemodynamically stable patients with dialysis-requiring AKI to receive dialysis either only upon meeting strict metabolic and clinical indications or on a standard thrice-weekly schedule. Strikingly, the conservative group demonstrated a significantly higher rate of kidney function recovery at hospital discharge (64% versus 50%) and fewer episodes of intradialytic hypotension. This suggests that minimizing dialysis frequency may reduce ischemic insults caused by hemodynamic instability, thereby accelerating renal recovery. However, listeners must approach these results with critical nuance: the study was unblinded, and notably, the statistical significance of the primary outcome was attenuated in the prespecified adjusted analysis (P = .15). Despite this limitation, the study offers vital clinical insight, challenging the dogma of rigid scheduling and suggesting that a personalized, "less is more" approach may be safe and potentially superior for facilitating dialysis liberation in stable AKI patients.

Citation: LIU, Kathleen D., et al. A Conservative Dialysis Strategy and Kidney Function Recovery in Dialysis-Requiring Acute Kidney Injury. JAMA. 2026. DOI: 10.1001/jama.2025.21530

Disclaimer: This audio summary is based on personal interpretation and does not guarantee the exact content of the original paper. Please refer to the original article for details.